177 related articles for article (PubMed ID: 24260299)
1. Teicoplanin as an effective alternative to vancomycin for treatment of MRSA infection in Chinese population: a meta-analysis of randomized controlled trials.
Peng Y; Ye X; Li Y; Bu T; Chen X; Bi J; Zhou J; Yao Z
PLoS One; 2013; 8(11):e79782. PubMed ID: 24260299
[TBL] [Abstract][Full Text] [Related]
2. Teicoplanin versus vancomycin for proven or suspected infection.
Cavalcanti AB; Goncalves AR; Almeida CS; Bugano DD; Silva E
Cochrane Database Syst Rev; 2010 Jun; (6):CD007022. PubMed ID: 20556772
[TBL] [Abstract][Full Text] [Related]
3. Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: meta-analysis of randomised controlled trials.
Jiang H; Tang RN; Wang J
Eur J Clin Microbiol Infect Dis; 2013 Sep; 32(9):1121-8. PubMed ID: 23568605
[TBL] [Abstract][Full Text] [Related]
4. High prevalence of isolates with reduced glycopeptide susceptibility in persistent or recurrent bloodstream infections due to methicillin-resistant Staphylococcus aureus.
Uçkay I; Bernard L; Buzzi M; Harbarth S; François P; Huggler E; Ferry T; Schrenzel J; Renzoni A; Vaudaux P; Lew DP
Antimicrob Agents Chemother; 2012 Mar; 56(3):1258-64. PubMed ID: 22155824
[TBL] [Abstract][Full Text] [Related]
5. Treatment of infective endocarditis caused by methicillin-resistant Staphylococcus aureus: teicoplanin versus vancomycin in a retrospective study.
Huang JH; Hsu RB
Scand J Infect Dis; 2008; 40(6-7):462-7. PubMed ID: 18584532
[TBL] [Abstract][Full Text] [Related]
6. Multicenter prospective observational study of the comparative efficacy and safety of vancomycin versus teicoplanin in patients with health care-associated methicillin-resistant Staphylococcus aureus bacteremia.
Yoon YK; Park DW; Sohn JW; Kim HY; Kim YS; Lee CS; Lee MS; Ryu SY; Jang HC; Choi YJ; Kang CI; Choi HJ; Lee SS; Kim SW; Kim SI; Kim ES; Kim JY; Yang KS; Peck KR; Kim MJ
Antimicrob Agents Chemother; 2014; 58(1):317-24. PubMed ID: 24165181
[TBL] [Abstract][Full Text] [Related]
7. Comparative efficacy of vancomycin and teicoplanin in the treatment of hospitalised elderly patients with persistent meticillin-resistant Staphylococcus aureus (MRSA) bacteraemia.
Lin SH; Lai CC; Tan CK; Liao WH; Hsueh PR
Int J Antimicrob Agents; 2011 Feb; 37(2):179-81. PubMed ID: 21163634
[No Abstract] [Full Text] [Related]
8. Linezolid vs. vancomycin in treatment of methicillin-resistant staphylococcus aureus infections: a meta-analysis.
Li J; Zhao QH; Huang KC; Li ZQ; Zhang LY; Qin DY; Pan F; Huang WX
Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3974-3979. PubMed ID: 28975963
[TBL] [Abstract][Full Text] [Related]
9. Linezolid versus vancomycin for the treatment of suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a systematic review employing meta-analysis.
Wang Y; Zou Y; Xie J; Wang T; Zheng X; He H; Dong W; Xing J; Dong Y
Eur J Clin Pharmacol; 2015 Jan; 71(1):107-15. PubMed ID: 25355172
[TBL] [Abstract][Full Text] [Related]
10. Antibiotic therapy for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) infections in surgical wounds.
Gurusamy KS; Koti R; Toon CD; Wilson P; Davidson BR
Cochrane Database Syst Rev; 2013 Aug; (8):CD009726. PubMed ID: 23963687
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic therapy for the treatment of methicillin-resistant Staphylococcus aureus (MRSA) in non surgical wounds.
Gurusamy KS; Koti R; Toon CD; Wilson P; Davidson BR
Cochrane Database Syst Rev; 2013 Nov; (11):CD010427. PubMed ID: 24242704
[TBL] [Abstract][Full Text] [Related]
12. Genomic insights on heterogeneous resistance to vancomycin and teicoplanin in Methicillin-resistant Staphylococcus aureus: A first report from South India.
Bakthavatchalam YD; Babu P; Munusamy E; Dwarakanathan HT; Rupali P; Zervos M; John Victor P; Veeraraghavan B
PLoS One; 2019; 14(12):e0227009. PubMed ID: 31887179
[TBL] [Abstract][Full Text] [Related]
13. Vancomycin versus teicoplanin in the therapy of experimental methicillin-resistant Staphylococcus aureus (MRSA) meningitis.
Sipahi OR; Arda B; Yurtseven T; Sipahi H; Ozgiray E; Suntur BM; Ulusoy S
Int J Antimicrob Agents; 2005 Nov; 26(5):412-5. PubMed ID: 16221540
[TBL] [Abstract][Full Text] [Related]
14. Optimal trough concentration of teicoplanin for the treatment of methicillin-resistant Staphylococcus aureus infection: A systematic review and meta-analysis.
Hanai Y; Takahashi Y; Niwa T; Mayumi T; Hamada Y; Kimura T; Matsumoto K; Fujii S; Takesue Y
J Clin Pharm Ther; 2021 Jun; 46(3):622-632. PubMed ID: 33547647
[TBL] [Abstract][Full Text] [Related]
15. Vancomycin or Daptomycin Plus a β-Lactam Versus Vancomycin or Daptomycin Alone for Methicillin-Resistant
Yi YH; Wang JL; Yin WJ; Xu WH
Microb Drug Resist; 2021 Aug; 27(8):1044-1056. PubMed ID: 33728980
[No Abstract] [Full Text] [Related]
16. Optimization of dosing regimens of vancomycin, teicoplanin, linezolid and daptomycin against methicillin-resistant
Wei X; Zhao M; Xiao X
J Chemother; 2021 Dec; 33(8):547-553. PubMed ID: 34080519
[TBL] [Abstract][Full Text] [Related]
17. Linezolid versus vancomycin or teicoplanin for nosocomial pneumonia: a systematic review and meta-analysis.
Kalil AC; Murthy MH; Hermsen ED; Neto FK; Sun J; Rupp ME
Crit Care Med; 2010 Sep; 38(9):1802-8. PubMed ID: 20639754
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of isolates with reduced glycopeptide susceptibility in orthopedic device-related infections due to methicillin-resistant Staphylococcus aureus.
Vaudaux P; Ferry T; Uçkay I; François P; Schrenzel J; Harbarth S; Renzoni A
Eur J Clin Microbiol Infect Dis; 2012 Dec; 31(12):3367-74. PubMed ID: 22833247
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic treatment for Clostridium difficile-associated diarrhea in adults.
Nelson RL; Kelsey P; Leeman H; Meardon N; Patel H; Paul K; Rees R; Taylor B; Wood E; Malakun R
Cochrane Database Syst Rev; 2011 Sep; (9):CD004610. PubMed ID: 21901692
[TBL] [Abstract][Full Text] [Related]
20. Daily practice and prognostic factors for pneumonia caused by methicillin-resistant Staphylococcus aureus in Japan: A multicenter prospective observational cohort study.
Miyazaki T; Yanagihara K; Kakeya H; Izumikawa K; Mukae H; Shindo Y; Yamamoto Y; Tateda K; Tomono K; Ishida T; Hasegawa Y; Niki Y; Watanabe A; Soma K; Kohno S
J Infect Chemother; 2020 Feb; 26(2):242-251. PubMed ID: 31575499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
